Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
November 30, 2017 12:00 pm GMT

Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes

Fractyl Labs, a Lexington, Massachusetts-based startup developing treatments for diabetes, has raised $44 million in Series D financing from a slew of VC firms, including GV, True Ventures, the IDO Fund, General Catalyst, Bessemer Venture Partners, Domain Associates, Mithril Capital Management, Emergent Medical Partners, L.P., and Deerfield Management Company, L.P. Fractyl has been working on… Read More

Original Link: http://feedproxy.google.com/~r/Techcrunch/~3/srXniWEn6bA/

Share this article:    Share on Facebook
View Full Article

Techcrunch

TechCrunch is a leading technology blog, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

More About this Source Visit Techcrunch